Quality indicators for endometrial cancer care in Japan
10.3802/jgo.2025.36.e77
- Author:
Tamaki KAKUWA
;
Yuichi ICHINOSE
;
Ryoko RIKITAKE
;
Taisuke ISHII
;
Satoru NAGASE
;
Yoichi KOBAYASHI
;
Masanori KANEUCHI
;
Hideki TOKUNAGA
;
Manabu SEINO
;
Hiroaki KAJIYAMA
;
Munetaka TAKEKUMA
;
Tsutomu TABATA
;
Yoshito TERAI
;
Yasuhisa TERAO
;
Tohru MORISADA
;
Hidemichi WATARI
;
Yoko YAMAMOTO
;
Akira KAWATA
;
Takahiro HIGASHI
- Publication Type:Original Article
- From:Journal of Gynecologic Oncology
2025;36(5):e77-
- CountryRepublic of Korea
- Language:English
-
Abstract:
Objective:The incidence and mortality rates of endometrial cancer are increasing globally, including in Japan. Quality of cancer care is promoted through guideline adherence. This study aimed to establish quality indicators (QIs) for endometrial cancer and explore the factors contributing to treatment nonadherence.
Methods:QIs and pattern-of-care indicators (PCIs) were developed using the Research and Development/University of California Los Angeles modified Delphi method. QIs reflect desirable healthcare patterns, whereas PCIs address treatment areas with lacking evidence.Data from the Hospital-Based Cancer Registry and Diagnosis Procedure Combination Survey were used. Patients diagnosed or treated between January 1 and December 31, 2020 were included. The reasons for nonadherence were collected. Logistic regression was used to analyze the factors influencing adherence, including age, body mass index, comorbidities, facilities, and recurrence risk.
Results:Of the 35 proposed QI candidates, 8 QIs and 9 PCIs were selected, predominantly focusing on surgical aspects. Adherence rates varied, with peritoneal lavage cytology being the highest (93.1%), and postoperative hormone replacement therapy (HRT) for patients aged <45 years being the lowest (30.9%), when focusing on process indicators. Reasons for nonadherence included patient preference and medical comorbidities as significant factors. Multivariate analysis highlighted age, clinical stage, and Barthel index as significant contributors to nonadherence.
Conclusion:We developed QIs to comprehensively assess endometrial cancer treatment.Adherence rates are favorable; however, HRT has a low adherence rate. Factors leading to nonadherence include advanced age and incomplete activities of daily living, particularly in advanced stages.
